Fei Wang, n/a

VP
Shanghai SIMR Biotechnology Co., Ltd.
Shanghai, Shanghai

10+ years experience in drug discovery in industry, inventor of 10+ clinical candidates

Presentation(s):

• P-071 - (Poster #71) Quantitative Sensory Testing of SR419, a First-in-Class Oral α5-GABAA Receptor Negative Allosteric Modulator, in Neuropathic Pain Patients

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST